ALAB Astera Labs, Inc.
Semiconductors & Related Devices · Nasdaq · SEC CIK 1736297 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY115.2%
TTM net income YoY132.0%
TTM EPS YoY107.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin73.9%
Operating margin25.5%
Net margin29.6%
FCF margin22.1%
EBITDA margin26.5%
Returns
ROE28.2%
ROA24.9%
ROIC (approx.)27.2%
Asset turnover0.84x
Leverage & solvency
Liabilities / assets13.1%
Debt / equity0.00x
Current ratio8.03x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.95x
Accruals ratio1.3%
Payout ratio—
Capex / revenue5.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $852.52M | $396.29M | $115.79M | $79.87M |
| Cost of revenue | $207.26M | $93.59M | $35.97M | $21.19M |
| Gross profit | $645.26M | $302.70M | $79.83M | $58.68M |
| R&D expense | $304.00M | $200.83M | $73.41M | $73.71M |
| SG&A expense | $88.07M | $94.28M | $15.93M | $20.76M |
| Operating income | $173.42M | -$116.07M | -$29.50M | -$60.19M |
| Pretax income | $218.15M | -$81.78M | -$22.95M | -$57.58M |
| Income tax | -$981,000 | $1.64M | $3.31M | $764,000 |
| Net income | $219.13M | -$83.42M | -$26.26M | -$58.34M |
| EBITDA | $180.25M | -$112.91M | -$27.72M | -$59.39M |
| EPS (basic) | 1.32 | -0.64 | -0.71 | -1.71 |
| EPS (diluted) | 1.22 | -0.64 | -0.71 | -1.71 |
| Weighted avg. shares (diluted) | 179.55M | 131.26M | 37.13M | 34.17M |
| Balance sheet | ||||
| Cash & equivalents | $167.61M | $80.04M | $45.10M | $76.09M |
| Short-term investments | $1.02B | $834.75M | $104.22M | — |
| Receivables | $83.20M | $38.81M | $8.34M | — |
| Inventory | $58.98M | $43.22M | $24.09M | — |
| Current assets | $1.36B | $1.01B | $185.81M | — |
| PP&E, net | $92.04M | $35.65M | $4.71M | — |
| Goodwill | $19.02M | — | — | — |
| Total assets | $1.53B | $1.05B | $196.29M | — |
| Current liabilities | $133.04M | $86.54M | $35.08M | — |
| Total liabilities | $168.19M | $89.71M | $38.87M | — |
| Shareholders' equity | $1.36B | $964.80M | -$97.70M | -$85.29M |
| Shares outstanding | 170.19M | 162.02M | 42.05M | — |
| Cash flow statement | ||||
| Operating cash flow | $319.31M | $136.68M | -$12.72M | -$35.90M |
| Capital expenditure | $37.54M | $34.24M | $2.76M | $3.87M |
| Free cash flow | $281.76M | $102.43M | -$15.48M | -$39.77M |
| Investing cash flow | -$241.47M | -$757.57M | -$17.77M | -$90.59M |
| Financing cash flow | $9.80M | $655.84M | -$502,000 | $151.67M |
| Depreciation & amortization | $6.83M | $3.15M | $1.78M | $807,000 |
| Stock-based compensation | $160.03M | $234.59M | $10.68M | $30.23M |
| Share buybacks | $0 | $1.07M | $210,000 | $313,000 |
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.